mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.3 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.3 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.3 |
mRNA |
IOX2 |
GDSC1000 |
pan-cancer |
AAC |
-0.043 |
0.3 |
mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.3 |
mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
-0.038 |
0.3 |